Blood-brain barrier-penetrating siRNA nanomedicine for Alzheimer's disease therapy.

Sci Adv · 2020 · PMC7546706 · PMID 33036977

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

* P < 0.05 was considered significant, and ** P < 0.01 *** P < 0.001 were considered highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.